TP53 and serous adenocarcinoma: The ubiquitous presence of TP53 mutations in HGSOC provides an important diagnostic feature for small tissue biopsies, particularly in distinguishing low‐grade serous carcinoma from HGSOC, and has been used for personalized disease monitoring using circulating tumour DNA in plasma samples 8, 9, 10, 11.